The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Previous research has also linked COVID to heart problems. For example, an oft-cited 2023 study published in the journal Nature Reviews Microbiology found that COVID infections "increased the risk of ...